.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Medtronic
Federal Trade Commission
Chubb
McKinsey
Moodys
Merck
Daiichi Sankyo
Cantor Fitzgerald
US Army

Generated: September 22, 2017

DrugPatentWatch Database Preview

QUININE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Quinine Sulfate, and what generic Quinine Sulfate alternatives are available?

Quinine Sulfate is a drug marketed by Lupin Ltd, Amneal Pharms, Teva Pharms, Riconpharma Llc, and Mylan Pharms Inc. and is included in five NDAs.

The generic ingredient in QUININE SULFATE is quinine sulfate. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

Summary for Tradename: QUININE SULFATE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list7
Bulk Api Vendors: see list135
Clinical Trials: see list721
Patent Applications: see list5,997
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:QUININE SULFATE at DailyMed

Pharmacology for Tradename: QUININE SULFATE

Drug ClassAntimalarial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL203112-001Apr 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Riconpharma Llc
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL204372-001Jul 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL203729-001Jul 15, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL091661-001Sep 28, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL202581-001Dec 14, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Accenture
Express Scripts
Merck
Healthtrust
Medtronic
McKesson
Citi
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot